Shaping Global Health Policy and Strategy
WHO Preferred Product Characteristics: Next-Generation Influenza Vaccines
Led development of WHO guidance defining priority characteristics for next-generation influenza vaccines, informing global R&D strategy and investment decisions.
Pandemic & Zoonotic Influenza Vaccines: Landscape Analysis and WHO Guidance
Analyzed global H5 vaccine pipelines and supported WHO consultations to inform pandemic preparedness and response strategies and guide decision-making on vaccine development priorities.
Evidence Generation and Analytical Insight
-
HIV Prevention and Program Science: Analysis and Policy Research
Conducted epidemiological and policy analyses to inform HIV prevention strategies and optimize program implementation across diverse settings.
-
Next-Generation Influenza Vaccine R&D Landscape: Analysis
Mapped the global pipeline of next-generation influenza vaccines to identify innovation gaps and strategic R&D priorities.
-
Global Influenza Vaccine Manufacturing Capacity: Analysis
Assessed global manufacturing capacity to identify bottlenecks and inform policy and investment strategies for pandemic preparedness.
Public Engagement and Science Communication
-
STEMHer South Africa: STEM Outreach and Digital Engagement
Designed and led a digital initiative expanding access to STEM education and career pathways for girls in underserved communities.
-
This Week in Global Health: Scientific Communication
Hosted a global health video series translating complex topics into accessible insights for public and professional audiences.